Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults

NCT02535806 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Funding source discontinued

Conditions

Acute Lymphoblastic Leukemia
Lymphoblastic Lymphoma

Interventions

DRUG: Velcade
DRUG: Methotrexate
DRUG: Methotrexate / Hydrocortisone / Cytarabine
DRUG: Dexamethasone
DRUG: Mitoxantrone
DRUG: Vincristine
DRUG: Pegaspargase

Sponsor

Children's Mercy Hospital Kansas City

Collaborators

[object Object]